Optimind Pharma Corp. (CSE:OMND)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Aug 19, 2025, 12:59 PM EST
0.00%
Market Cap 515.74K
Revenue (ttm) 124.01K
Net Income (ttm) -46.88K
Shares Out 103.15M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,000
Average Volume 18,580
Open 0.0050
Previous Close 0.0100
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.0100
Beta 0.16
RSI 45.97
Earnings Date Jan 29, 2026

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada. [Read more]

Sector Healthcare
CEO David Goodman
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol OMND
Full Company Profile

Financial Performance

In 2024, Optimind Pharma's revenue was 118,368, a decrease of -3.73% compared to the previous year's 122,959. Losses were -215,812, -84.56% less than in 2023.

Financial Statements

News

There is no news available yet.